Tran Nhu N, Miner Anna, Adeleke Eniola, Phan Rene, Brady Ken M, Brecht Mary-Lynn, Friedlich Philippe, Zhou Geena, Rajagopalan Vidya, Peterson Bradley S, Votava-Smith Jodie K
Institute for the Developing Mind, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Fetal and Neonatal Institute, Division of Neonatology, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Front Pediatr. 2025 Feb 14;13:1482257. doi: 10.3389/fped.2025.1482257. eCollection 2025.
1st: To determine the association of cerebral oxygenation (rcSO) and concurrent neurodevelopmental outcomes between neonates with congenital heart disease (CHD) and healthy controls. 2nd: To examine the association of cerebral fractional tissue oxygen extraction (FTOE) with concurrent neurodevelopmental outcomes in the two groups. 3rd: To evaluate how type and severity of CHD influenced the associations in our primary and secondary objectives.
Our secondary analysis included 137 neonates (74 with CHD and 63 healthy controls). We used linear regression models to examine the association of the predictors (i.e., cerebral oxygenation, FTOE, type and severity of CHD) with the percentage of abnormal neurobehavioral scores (outcome). The models included the main effects of group, rcSO, and a rcSO-by-group interaction (examined differences between groups) with covariates of postconceptional age at exam, sex, ethnicity, and preductal peripheral oxygen saturation on the percentage of abnormal neurobehavioral scores. We also performed separate regression models separately in each group. We used these models for the 2nd and 3rd objectives, replacing rcSO with FTOE and type and severity of CHD as predictors.
Neonates with CHD had lower rcSO values (67% vs. 79%; < 0.001) and higher FTOE values (0.27 vs. 0.19; < 0.001) compared to healthy controls. The association of rcSO with the neurobehavioral scores significantly differed between groups ( = 0.004). In the CHD group, increased rcSO showed a trend toward better neurodevelopmental outcomes. However, increased rcSO associated significantly with poorer neurodevelopmental outcomes in the healthy group. Additionally, FTOE significantly differed between groups ( = 0.012). The CHD group showed a trend towards increased FTOE and poorer neurodevelopmental outcomes. Conversely, increased FTOE associated significantly with better neurodevelopmental outcomes in the healthy group.
The CHD and healthy neonates had significantly different associations of both rcSO and FTOE with the neurobehavioral scores. Our findings suggest that both increased and decreased rcSO and FTOE may negatively affect concurrent neurodevelopmental outcomes in neonates. Our findings also imply a critical range of rcSO values, where extreme oxygenation on either side may be harmful. Neonates with CHD and healthy controls may exhibit different neurodevelopmental responses to increased rcSO and FTOE due to differing metabolic demands.
第一,确定先天性心脏病(CHD)新生儿与健康对照组之间脑氧合(rcSO)与同期神经发育结局的关联。第二,研究两组中脑组织氧分数提取率(FTOE)与同期神经发育结局的关联。第三,评估CHD的类型和严重程度如何影响我们主要和次要目标中的关联。
我们的二次分析纳入了137例新生儿(74例CHD患儿和63例健康对照)。我们使用线性回归模型来研究预测因素(即脑氧合、FTOE、CHD的类型和严重程度)与异常神经行为评分百分比(结局)之间的关联。模型包括组、rcSO的主效应以及rcSO与组的交互作用(检查组间差异),同时将检查时的孕龄、性别、种族以及导管前外周血氧饱和度作为异常神经行为评分百分比的协变量。我们还在每组中分别进行了单独的回归模型分析。我们将这些模型用于第二个和第三个目标,将rcSO替换为FTOE,并将CHD的类型和严重程度作为预测因素。
与健康对照组相比,CHD新生儿的rcSO值较低(67%对79%;P<0.001),FTOE值较高(0.27对0.19;P<0.001)。rcSO与神经行为评分的关联在两组之间存在显著差异(P=0.004)。在CHD组中,rcSO升高显示出神经发育结局改善的趋势。然而,在健康组中,rcSO升高与较差的神经发育结局显著相关。此外,FTOE在两组之间存在显著差异(P=0.012)。CHD组显示出FTOE升高和神经发育结局较差的趋势。相反,在健康组中,FTOE升高与较好的神经发育结局显著相关。
CHD新生儿和健康新生儿在rcSO和FTOE与神经行为评分的关联方面存在显著差异。我们的研究结果表明,rcSO和FTOE的升高和降低都可能对新生儿同期神经发育结局产生负面影响。我们的研究结果还暗示了rcSO值的一个关键范围,在此范围内两侧的极端氧合可能都是有害的。由于代谢需求不同,CHD新生儿和健康对照组可能对rcSO和FTOE升高表现出不同的神经发育反应。